FDA Inspection 960768 — South Texas Blood & Tissue Center

South Texas Blood & Tissue Center — FEI 1676815

The FDA completed an inspection of South Texas Blood & Tissue Center on Feb 1, 2016 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 1, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.